Activist Investor Pressure Mounts for a Competitive Sale of Ashland Inc. (NYSE: ASH)

• Activist investor Ancora Holdings Group is advocating for a competitive sale of Ashland Inc. (NYSE: ASH), a specialty materials company.
• Ancora argues that Ashland Inc. suffers from a "conglomerate discount," with its Life Sciences and Personal Care segments representing 75% to 80% of total EBITDA.
• Despite recent share price drops following missed earnings, analyst firm UBS has reiterated a Buy rating and raised its price target to $72.

Ashland Inc., a leading specialty materials company, is currently facing significant pressure from activist investor Ancora Holdings Group. Ancora has released a detailed presentation advocating for a competitive sale of the company. The firm plans to engage directly with Ashland Inc.'s board of directors to evaluate a potential sale against the company's existing standalone strategy.

Ancora argues that Ashland Inc. trades at a "conglomerate discount," suggesting the market undervalues the company compared to the sum of its individual business parts. The activist investor highlights the company's Life Sciences and Personal Care segments as its most valuable assets. These "crown jewels" reportedly represent approximately 75% to 80% of total EBITDA.

The investor group criticizes Ashland Inc.'s recent financial performance, as highlighted by Business Wire. The specialty materials company has missed consensus earnings estimates in four of the last five quarters. Following a disappointing earnings report for the second quarter of 2026, Ashland Inc.'s share price dropped by nearly 15%, signaling low investor confidence.

A potential sale of Ashland Inc. is further supported by existing investor interest. Standard Industries' investment arm already owns about 9.9% of the company. Ancora estimates a potential sale price of $76.47 per share. Meanwhile, analyst firm UBS reiterated its Buy rating and raised its price target on Ashland Inc. to $72 from $66.

The stock currently trades at $65.24, within a 52-week range of $46.30 and $67.20. At the time of the UBS update, the stock was at $62.50 per share. Ashland Inc. has a market capitalization, which is the total value of all its shares, of around $2.99 billion.